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1. Introduction 
The successful use of enzymes in the treatment 
of inherited enzyme deficiencies and other disorders 
in man can be limited by several problems [l] , a- 
mong which immune responses to the administered, 
foreign to the body, enzyme are prominent. Entrap- 
ment of enzymes [2] or drugs [3] before their ad- 
ministration in liposomes, which are concentric lipid 
bilayers alternating with aqueous compartments [4], 
has been suggested as a means of directing therapeu- 
tic agents in isolation from the environment to dis- 
eased areas of the body. It was hoped that such 
a specific approach to therapy would not only cir- 
cumvent possible incompatibility of administered 
agents with blood (e.g inactivation of some enzymes 
by their inhibitors in blood [S] or toxic action of 
some agents on blood elements) and non-specific 
uptake by the reticula-endothelial system but also 
primary immune responses to antigenic agents. EX- 
periments have shown that the activity of lipsome- 
entrapped enzymes in blood when injected into rats, 
retains its latency [6,7] and that such enzymes 
within liposomes are rapidly taken by endocytosis 
[8] into the liver and spleen lysosomes [6-81 where 
they are catabolised. The rate of degradation can be 
considerably decreased by cross-linking the enzyme 
after its entrapment in liposomes [9] and recently, 
enzyme-containing liposomes have been shown to 
alleviate a model for lysosomal storage diseases [lo]. 
While these findings support the concept of liposomes 
as carriers of enzymes in the,treatment of lysosomal 
storage diseases [ 11, the possibility of greatly aug- 
menting the life span of liposomes in the blood by 
the adjustment of their surface charge [9] has given 
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promising indications for the use of liposomes also as 
carriers of enzymes intended to act on small molec- 
ular weight substrates in blood able to diffuse through 
the lipid bilayers of liposomes. 
In the present work the immune responses of 
mice injected with liposome-entrapped diphtheria 
toxoid were examined. It was found that although 
primary immune response to liposome-entrapped 
proteins was not abolished, occurrence of allergic 
reactions upon repeated challenge with the entrap- 
ped antigen was prevented. 
2. Materials and methods 
Diphtheria toxoid, purchased from Wellcome Re- 
search Laboratories, Beckenham, Kent, U.K., was 
iodinated with “‘1 by the iodine monochloride 
method [ 1 I] and subsequently dialysed exhaustive- 
ly against 1% NaCl. Sources and grades of phos- 
phatidylcholine, cholesterol, stearylamine and phos- 
phatidic acid have been described elsewhere [3], 
For entrapment [3,6] in negatively charged liposo- 
mes 15.00 mg egg phosphatidylcholine, 2.20 mg 
cholesterol and 2.12 mg phosphatidic acid (molar 
ratio 7: 2: 1) in CHC 1 3 were used and for entrapment 
in positively charged liposomes phosphatidic acid 
was replaced with 0.81 mg stearylamine. Following 
rotary evaporation of the solvent under reduced 
pressure, the thin lipid layer on the walls of the 
flask was dispersed with 2 ml ‘251-labelled diph- 
theria toxoid (12 mg/ml) adjusted to pH 7.2 with 
sodium phosphate buffer (final molarity 5 mM) or 
to pH 4.5 with sodium acetate buffer (final molarity 
0.05 M) in the case of positively charged liposomes. 
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The suspension was then sonicated [2] for 10 set 
and subsequently passed through a Sepharose 6B 
(Pharmacia) column (1 X 28 cm) to separate the 
protein-containing liposomes from the non-entrap- 
ped protein. 
For immunization with diphtheria toxoid, adult 
mice (T. 0. strain) of both sexes in groups of 5 or 
6 were injected intravenously with liposome-entrap- 
ped or non-entrapped diphtheria toxoid dissolved 
in 5 mM sodium phosphate buffer pH 7.2 containing 
1% NaCl (PBS). Two to three weeks later the mice 
were bled, subsequently challenged for a second 
time and again bled about two weeks later. Some 
groups of mice were challenged for a third and fourth 
time. Blood from the tail vein was collected in he- 
parinised microcapillaries, centrifuged in a Microhae- 
matocrit centrifuge (Hawksley) and the plasma assay- 
ed for the antibody titre by passive agglutination 
[ 121. Mice previously challenged twice with non- 
entrapped or liposome-entrapped iphtheria toxoid 
were tested for the Arthus reaction: 10 ~1 of non- 
entrapped (0.01 mg) or liposome-entrapped (0.01 
mg) diphtheria toxoid was injected into the right foot 
pad of the hind leg. The left food pad which served 
as control was injected with appropriate volumes of 
PBS. Four hr later and again at 24 and 48 hr the 
thickness of the foot was measured with a micro- 
meter gauge. Other groups of mice previously chal- 
lenged 2-4 times with non-entrapped or liposome- 
entrapped diphtheria toxoid were injected intravenous- 
ly with either 0.3 ml of non-entrapped (0.40 mg) or 
liposome-entrapped (0.40 mg) diphtheria toxoid and 
observed for serum sickness. In one experiment 
groups of intact and immune mice were injected 
intravenously with non-entrapped and liposome- 
entrapped lz5 I-labelled diphtheria toxoid as shown in 
table 3 and killed at time intervals. Radioactivity was 
then measured [3] in the plasma, liver, spleen and 
kidney. 
3. Results and discussion 
Entrapment of diphtheria toxoid in liposomes did 
not prevent the formation of antibodies in injected 
mice, and antibody titres were not lower than those 
measured in mice injected with the non-entrapped 
protein (see legend to table 1). Table 1 presents 
results from the Arthus reaction test on pre-immu- 
nised mice, expressed as the ratio of thickness of the 
foot pad injected with the antigen and that of the foot 
pad injected with PBS. It appears that regardless of 
the state of the antigen (entrapped or non-entrapped) 
with which mice were immunised, there was a 
moderately strong Arthus reaction (ratio 1.42) 4 hr 
after injection when non-entrapped diphtheria toxoid 
was used for the test, and no reaction, or a weak one 
(ratio, 1.07) when liposome-entrapped antigen was 
used. The absence of swelling at the sites of injection 
24 or 48 hr later suggested that there was no delayed 
hypersensitivity. Preliminary experiments with mice 
immunised with non-entrapped or liposome-entrapped 
asparaginase suggest hat with this protein too there 
is antibody formation despite liposomal entrapment 
Table 1 
Arthus reaction in immune mice 
No. of 
mice 
Challenge 
Mean ratio 
of foot pad 
thickness 
Range Probability 
10 Non-entrapped DT 
8 Liposome-entrapped DT 
1.42 1.05-1.83 
1.07 1.00-1.15 < 0.01 
Mice, previously immunised by the intravenous route with non-entrapped or liposome- 
entrapped diptheria toxoid (DT) and with comparable concentrations of antibody against 
diphtheria toxoid were challenged by injection into the hind foot pad on one side of either 
10 ~1 non-entrapped DT (0.01 mg protein) or 10 ~1 liposome-entrapped DT (0.01 mg 
protein and 0.15 mg lipid) diphtheria toxoid and on the other side by injection of 1% NaCl. 
Four hr later the thickness of each of the foot pads was measured and ratios calculated 
(see the Materials and methods section). 
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which, however, again inhibits the appearance of 
Arthus reaction. 
The protection offered by the lipid bilayers to the 
entrapped antigen in preventing antigen-antibody 
interactions was further demonstrated in experiments 
in which mice pre-immunised with non-entrapped or 
liposome-entrapped iphtheria toxoid were injected 
intravenously with a large quantity (0.40 mg) of non- 
entrapped or liposome-entrapped iphtheria toxoid 
(table 2). Five out of seven mice injected with the 
non-entrapped antigen died within minutes and two 
were very ill but eventually recovered. All mice given 
Table 2 
Serum sickness in immune mice 
No. of 
mice 
Challenge 
Survived 
mice 
7 Non-entrapped DT 2 
7 Liposome-entrapped DT I 
Mice with comparable concentrations of antibody against 
diphtheria toxoid (DT) were injected in their tail vein with 
0.3 ml non-entrapped DT (0.40 mg protein) or 0.3 ml 
liposome-entrapped DT (0.40 mg protein and 6.6 mg lipid) 
and were observed for serum sickness. In contrast to the 
survivors in the group of mice treated with non-entrapped 
DT, which were initially very ill, none of the mice treated 
with liposome-entrapped DT showed any side effects. 
the antigen entrapped in liposomes appeared normal 
(table 2) presumably because liposome-entrapped 
diphtheria toxoid did not interact with circulating 
antibodies. This was shown to be the case in experi- 
ments’in which intact and immune mice were injected 
with non-entrapped and liposome-entrapped ’ 2s I- 
labelled diphtheria toxoid and killed 20 min later 
(table 3). Assay of radioactivity in the blood and tis- 
sues revealed that although there was an enhanced 
removal of the injected non-entrapped antigen from 
the blood and increased localisation in the liver of 
immune mice, most of the diphtheria toxoid entrap- 
ped in either negatively charged or positively charged 
liposomes injected in such mice followed the fate of 
its carrier. There was no difference in radioactivity 
deposition in the spleen and kidneys between intact 
and immune mice (table 3). 
The present findings indicate that although entrap- 
ment in liposomes of an antigen before its injection 
into mice does not prevent the eventual development 
of an immune response, it nevertheless markedly 
inhibits the interaction of the antigen with its anti- 
bodies in vivo upon repeated challenge, thus pre- 
venting the development of severe, or even fatal, 
allergic reactions. Repeated administration of liposome- 
entrapped therapeutic enzymes in man may therefore 
prove immunologically safe. 
Table 3 
Fate of non-entrappea nd liposome-entrapped 12sI-labelled iphtheria toxoid injected into immune mice 
Blood Liver Kidney Spleen 
Treatment 
Intact Immune Intact Immune Intact Immune Intact Immune 
Non-entrapped DT 
9.8 3.3 24.0 54.2 2.6 2.6 2.3 2.3 
10.1 2.5 20.1 59.3 3.0 4.5 2.6 1.0 
DT entrapped in negative liposomes 
4.6 3.8 42.9 44.1 2.0 1.7 2.1 0.8 
6.0 4.4 40.6 42.4 2.3 1.2 1.9 3.5 
DT entrapped in positive liposomes 8.5 7.1 32.1 35.1 2.6 2.8 2.4 2.2 
8.6 6.8 28.4 34.5 2.6 3.3 2.2 1.4 
Intact and immune mice with comparable concentrations of antibody against diphtheria toxoid (DT) were injected in their tail 
vein with 0.35 ml of non-entrapped iphtheria toxoid (0.18 mg protein and 2.1 X lo4 cpm) and diphtheria toxoid entrapped in 
negatively charged (0.18 mg protein, 2.8 X lo4 cpm and 3.5 mg lipid) or positively charged liposomes (0.18 mg protein, 
2.8 X lo4 cpm and 3.9 mg lipid). All mice were killed 20 min after injection and radioactivity was measured in blood and tissues, 
corrected for blood contamination [ 91 and expressed as percent of the injected dose per 1 ml blood or total tissue. 
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